Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2016 1
2017 2
2019 3
2020 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
Oxo-aglaiastatin-Mediated Inhibition of Translation Initiation.
Itoua Maïga R, Cencic R, Chu J, Waller DD, Brown LE, Devine WG, Zhang W, Sebag M, Porco JA Jr, Pelletier J. Itoua Maïga R, et al. Among authors: devine wg. Sci Rep. 2019 Feb 4;9(1):1265. doi: 10.1038/s41598-018-37666-5. Sci Rep. 2019. PMID: 30718665 Free PMC article.
Amidino-Rocaglates: A Potent Class of eIF4A Inhibitors.
Chu J, Zhang W, Cencic R, Devine WG, Beglov D, Henkel T, Brown LE, Vajda S, Porco JA Jr, Pelletier J. Chu J, et al. Among authors: devine wg. Cell Chem Biol. 2019 Nov 21;26(11):1586-1593.e3. doi: 10.1016/j.chembiol.2019.08.008. Epub 2019 Sep 10. Cell Chem Biol. 2019. PMID: 31519508 Free PMC article.
Rocaglates Induce Gain-of-Function Alterations to eIF4A and eIF4F.
Chu J, Zhang W, Cencic R, O'Connor PBF, Robert F, Devine WG, Selznick A, Henkel T, Merrick WC, Brown LE, Baranov PV, Porco JA Jr, Pelletier J. Chu J, et al. Among authors: devine wg. Cell Rep. 2020 Feb 25;30(8):2481-2488.e5. doi: 10.1016/j.celrep.2020.02.002. Cell Rep. 2020. PMID: 32101697 Free PMC article.
Structure-property studies of an imidazoquinoline chemotype with antitrypanosomal activity.
Klug DM, Diaz-Gonzalez R, DeLano TJ, Mavrogiannaki EM, Buskes MJ, Dalton RM, Fisher JK, Schneider KM, Hilborne V, Fritsche MG, Simpson QJ, Tear WF, Devine WG, Pérez-Moreno G, Ceballos-Pérez G, García-Hernández R, Bosch-Navarrete C, Ruiz-Pérez LM, Gamarro F, González-Pacanowska D, Martinez-Martinez MS, Manzano-Chinchon P, Navarro M, Pollastri MP, Ferrins L. Klug DM, et al. Among authors: devine wg. RSC Med Chem. 2020 Jul 10;11(8):950-959. doi: 10.1039/d0md00103a. eCollection 2020 Aug 1. RSC Med Chem. 2020. PMID: 33479690
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma.
Manier S, Huynh D, Shen YJ, Zhou J, Yusufzai T, Salem KZ, Ebright RY, Shi J, Park J, Glavey SV, Devine WG, Liu CJ, Leleu X, Quesnel B, Roche-Lestienne C, Snyder JK, Brown LE, Gray N, Bradner J, Whitesell L, Porco JA Jr, Ghobrial IM. Manier S, et al. Among authors: devine wg. Sci Transl Med. 2017 May 10;9(389):eaal2668. doi: 10.1126/scitranslmed.aal2668. Sci Transl Med. 2017. PMID: 28490664 Free PMC article.